Our results indicated that ORC6 may be treated a potential diagnostic and prognostic biomarker for patients with ccRCC, and that ORC6 knockdown suppressed malignancy of ccRCC in vitro. This evidence concerns the gene ORC6 and nonpapillary renal cell carcinoma.